Agena Bioscience, Inc. – Trademark Portfolio
Entity Type: 03
Agena Bioscience, Inc. holds 22 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 12 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. Currently, 11 trademarks are registered and 1 is pending. Notable registered marks include IPLEX, HEMO ID, TYPERDX, EPITYPER, and LIQUIDIQ. The owner is based in San Diego, CA.
4755 Eastgate Mall
San Diego, CA 92121
Showing of trademarks Trademarks
Trademark Classifications
Agena Bioscience, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Agena Bioscience, Inc. have?
Agena Bioscience, Inc. has 22 U.S. trademarks filed with the USPTO. Of these, 11 registered, 1 pending, 9 abandoned, 1 cancelled.
What trademark classes does Agena Bioscience, Inc. file in?
Agena Bioscience, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are Agena Bioscience, Inc.'s most well-known trademarks?
Agena Bioscience, Inc.'s registered trademark portfolio includes well-known marks such as IPLEX, HEMO ID, TYPERDX, EPITYPER, and LIQUIDIQ. These are among 11 currently registered trademarks in the portfolio.
What is Agena Bioscience, Inc.'s trademark registration success rate?
Agena Bioscience, Inc. has a 52% trademark registration rate, with 11 out of 21 resolved applications resulting in successful registration. Currently, 1 application is pending review.